AIP Capital Announces Dimuth Fernando as Chief Commercial Officer
STAMFORD, Conn. and SINGAPORE and DUBLIN and NEW YORK, March 9, 2026 /PRNewswire/…
CORRECTING & REPLACING — MBX Biosciences Announces Successful End-of-Phase 2 FDA Meeting and Provides Phase 3 Development Plan for Once-Weekly Canvuparatide for Hypoparathyroidism
Following End-of-Phase 2 meeting, MBX remains on track to initiate Phase 3…
Crescent Biopharma Announces Grants of Inducement Awards
March 06, 2026 16:15 ET | Source: Crescent Biopharma, Inc. WALTHAM, Mass.,…
UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PRINCETON, N.J., March 06, 2026 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq:…
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 06, 2026 17:33 ET | Source: Tango Therapeutics Sub, Inc BOSTON,…
Revive Environmental Announces CEO Transition
COLUMBUS, Ohio, March 06, 2026 (GLOBE NEWSWIRE) -- Revive Environmental Technology, LLC,…
Bybit Announces Departure of Co-CEO Helen Liu as She Embarks on Entrepreneurial Journey
DUBAI, UAE, March 7, 2026 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency…
AIM ImmunoTech Announces Closing of its Rights Offering
OCALA, Fla., March 06, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE…
Fennec Pharmaceuticals Announces Clinical Research Collaboration with Tampa General Hospital Cancer Institute
Study is Real-World Evaluation of the Clinical Utility of Sodium Thiosulfate Injection (PEDMARK®)…
The Ferrero Group announces new governance and leadership roles, reporting into Giovanni Ferrero, President of Ferrero International S.A.
Alessandro Nervegna will be appointed as new Chief Executive Officer of Ferrero…
